Search clinical trials for: DPP IV Inhibitor

Total 80194 results

Mayo Clinic

Recruiting

Anti-Diabetic Medications to Fight PD and LBD

Parkinson Disease | Lewy Body Dementia

United States
Beni-Suef University
Faculty of Medicine, Minia University; Clinical Pharmacy Department, Faculty...

Not yet recruiting

The Effects of DPPIs on Cognitive Function of Diabetic Patients

Cognitive Impairment

Egypt
Thermosome GmbH

Recruiting

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Sarcoma, Soft Tissue

Germany
MTI University
National Institute of Diabetes and Endocrinology, Egypt

Recruiting

The Effect of Metformin and DPP4 Inhibitors on Cognition and Cardiovascular Protection in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Egypt
Peking University People's Hospital
Peking University First Hospital; Jiangsu Province Geriatric Institute

Recruiting

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

Diabetes Mellitus, Type 2 | Severe Insulin Deficient Diabetes

China
LG Chem

Not yet recruiting

Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg

Healthy Volunteers
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Oral Anti Diabetic Agents in the Hospital

Diabetes Mellitus

United States
University of Pennsylvania

Recruiting

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Heart Failure | Type2 Diabetes | Genetics Disease

United States
Medical University of Vienna

Recruiting

Effects of Different Types of General Anesthesia on Postoperative Pupillary Reactivity

Pupillary Reflex Impaired

Austria
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empa PASS on Urinary Tract Malignancies

Diabetes Mellitus, Type 2

Finland, Sweden, United Kingdom
SINA Health Education and Welfare Trust
Horizon Pharmaceutical Pvt Ltd

Completed

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | Empagliflozin

Pakistan
Ain Shams University

Completed

Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes

Diabetes Mellitus, Type 1 | NASH

Egypt
Qianfoshan Hospital

Active, not recruiting

Therapeutic Drug Use for CKD Patients

Chronic Kidney Disease

China
Sadat City University

Active, not recruiting

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

Major Depressive Disorder

Egypt
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Myocardial Infarction | Heart Failure | Ischemic Stroke | Type2 Diabetes | Cardiovascular Death | All-Cause Mortality

Canada
Takeda

Completed

Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus (TRENDS)

Type 2 Diabetes

Japan
Takeda

Completed

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus (TRINITY)

Type 2 Diabetes Mellitus

Japan
Weill Medical College of Cornell University
Patient-Centered Outcomes Research Institute

Completed

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Diabetes Mellitus, Type 2 | Renal Insufficiency, Chronic

United States
AstraZeneca

Completed

Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) (HARRP)

Type 2 Diabetes Mellitus

Sweden
Ain Shams University

Completed

Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System

Time in Range

Egypt
Celltrion Pharm, Inc.

Active, not recruiting

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy (EPIDOTE)

Diabetes Mellitus, Type 2

Korea, Republic of
University Hospital Muenster

Completed

Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass (SiCa-Flam)

Systemic Inflammatory Response Syndrome

Germany
Brigham and Women's Hospital

Completed

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Diabetes

United States
Brigham and Women's Hospital

Completed

Replication of the CANVAS Diabetes Trial in Healthcare Claims

Diabetes

United States
Brigham and Women's Hospital

Completed

Replication of the EMPAREG Diabetes Trial in Healthcare Claims

Diabetes

United States
Brigham and Women's Hospital

Completed

Replication of the LEADER Diabetes Trial in Healthcare Claims

Diabetes

United States
Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Diabetes

United States
Boehringer Ingelheim
Eli Lilly and Company

Active, not recruiting

Comparative Effectiveness of Empagliflozin in the US

Diabetes Mellitus, Type 2

United States
Johns Hopkins University

Terminated

Glycemia in Diabetic Elders Trial

Type 2 Diabetes Mellitus

United States
Oregon Health and Science University

Suspended

Effects of DPP-4 Inhibition on Triglycerides

Type 2 Diabetes | Hypertriglyceridemia

United States
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium
The Catholic University of Korea

Completed

DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy

Diabetes Mellitus

Korea, Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Diabetes Mellitus, Type 2

United Kingdom
Shanghai 10th People's Hospital

Completed

Non-alcoholic Fatty Liver Disease and Its Treatment

NAFLD
Chungbuk National University Hospital

Completed

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
AstraZeneca
Parexel

Completed

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)

Germany
Khoo Teck Puat Hospital

Completed

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Type II Diabetes in Subjects BMI 27 to 32

Singapore
AstraZeneca

Terminated

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Type 2 Diabetes Mellitus

Thailand, Vietnam
University of Pavia

Completed

Use of Incretins in Diabetic Patients

Diabetes Mellitus, Type 2

Italy
Sadat City University
Beni-Suef University

Completed

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Diabete Type 2

Egypt
GRADE Study Group
Bristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney... and other collaborators

Completed

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE)

Type 2 Diabetes | Comparative Effectiveness of Glycemia-lowering Medications

United States
Vanderbilt University

Completed

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Hypertension | Type 2 Diabetes Mellitus

United States
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
Boehringer Ingelheim

Completed

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Diabetes Mellitus, Type 2

Saudi Arabia
Boehringer Ingelheim

Completed

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
M.H.H. Kramer

Active, not recruiting

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES (RACELINES)

Type2 Diabetes

Netherlands
Metabolic Research Unit

Enrolling by invitation

ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT

Type 2 Diabetes | Abdominal Obesity

Mexico

Search clinical trials for: DPP IV Inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations